<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors report a case of second degree <z:hpo ids='HP_0001678'>heart block</z:hpo> associated with topical <z:chebi fb="0" ids="6384">latanoprost</z:chebi> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The authors discuss the possibility of a causative effect as the cessation of this treatment resulted in improvement of the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The authors highlight previous reports and research in humans and animals which demonstrate an association of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> with <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> analogues </plain></SENT>
<SENT sid="3" pm="."><plain>This report draws attention to the possibility that an extremely commonly prescribed topical drug may trigger <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in susceptible individuals </plain></SENT>
<SENT sid="4" pm="."><plain>It is important that prescribers are aware of this possible side-effect </plain></SENT>
</text></document>